Cenexi
Who owns Cenexi?
Cenexi is a French Pharma company, now owned by Gland Pharma, which acquired it in 2023 from Cathay Capital.
Indigo Capital is still listed as an investor in Cenexi, status not confirmed after the 2023 sale.
Hand-verified · updated 2026-09-30
Open JSON · CC-BYKey facts
- ·Held by Indigo Capital since 2017 (9Y hold).
- ·Average hold across 2 realized cycles: 8 years.
Ownership history
3 ownership periods · co-invest detected
Chequers Capital sold Cenexi to Cathay Capital in 2016 after 8 years.
Cathay Capital sold Cenexi to Gland Pharma in 2023 after 8 years.
More from Indigo Capital I
Other portfolio companies in the same fund.
More PE-backed in Pharma
Comparable pharma deals from other GPs.
Questions
Who owns Cenexi?
Cenexi is now owned by Gland Pharma, which acquired it in 2023 from Cathay Capital. Indigo Capital is still listed as an investor in Cenexi, status not confirmed after the 2023 sale.
When did Gland Pharma acquire Cenexi?
Gland Pharma acquired Cenexi in 2023, buying from Cathay Capital.
Who did Cenexi sell to?
Cathay Capital sold Cenexi to Gland Pharma in 2023 (Trade Sale). Chequers Capital sold Cenexi to Cathay Capital in 2016 (Secondary).
Who has owned Cenexi over time?
Cenexi has been through 3 private-equity ownership periods: Chequers Capital · via Chequers Capital XV · 2008–2016 · sold to Cathay Capital · (Secondary); Cathay Capital · via Cathay Capital Midcap I · 2015–2023 · sold to Gland Pharma · (Trade Sale); Indigo Capital · via Indigo Capital I · since 2017.